RSS

Combating Antibiotic Resistant Bacteria Accelerator (CARB-X)

Biotech company Oxford Drug Design has been awarded over £8 million to develop new antibiotics effective against drug-resistant superbugs. Read more

News

An affiliate of PureTech Health, Vedanta Biosciences, has been awarded a research grant of up to $5.4 million from Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) to support clinical testing of its lead product Read more

News

Clinical-stage biotechnology company, Visterra, has been awarded a research and development contract from the public-private partnership, Combating Antibiotic Resistant Bacteria Accelerator (CARB-X). Read more

News